Advancing mRNA-based drug development and vaccine manufacturing

Shared by Parexel experts, Christiane Niederlaender, Cecil Nick, and Sinan Sarac covering on the topics of:

Section 1 - Overview of mRNA Product Manufacturing Challenges
Section 2 - Optimizing the Path to Regulatory Approval for Novel Vaccine
Section 3 - Accelerating Approval of mRNA vaccines for Oncology Drug development

Return to Insights Center

Related Insights

Webinar

Accelerating delivery of radiopharmaceutical trials

Oct 3, 2025

Blog

PD-1 inhibitors face scrutiny in esophageal cancer: Key takeaways for drug developers

Oct 4, 2024

Article

Five strategies for meeting the requirements of Project Optimus and improving the chances of approval

Nov 10, 2022

Article

Q&A Project Optimus: What you need to know

Oct 11, 2022

Blog

Making cell and gene therapy more accessible in the treatment of solid tumors

Jun 4, 2024

Webinar

Challenges and best practices for developing Antibody-Drug Conjugates (ADCs)

Nov 12, 2024

Blog

Navigating the path to conditional approval: avoiding pitfalls in oncology drug applications

Feb 4, 2025

Webinar

Navigating the complexities of AML drug development

Oct 30, 2024

Blog

Ensuring future success in a new market by delivering a robust safety database solution

Aug 4, 2023

Blog

A hybrid model supports globally diverse site participation for a retrospective cancer study

Jul 24, 2023

Article

The technologies that are reshaping biotherapeutics manufacturing, an EU perspective

Jul 6, 2023

Whitepaper

How to prepare for Policy 0070: Challenges and opportunities for clinical data publication in the EU

Jun 28, 2023

Related Insights

Webinar

Accelerating delivery of radiopharmaceutical trials

Oct 3, 2025

Blog

PD-1 inhibitors face scrutiny in esophageal cancer: Key takeaways for drug developers

Oct 4, 2024

Article

Five strategies for meeting the requirements of Project Optimus and improving the chances of approval

Nov 10, 2022

Article

Q&A Project Optimus: What you need to know

Oct 11, 2022

Blog

Making cell and gene therapy more accessible in the treatment of solid tumors

Jun 4, 2024

Webinar

Challenges and best practices for developing Antibody-Drug Conjugates (ADCs)

Nov 12, 2024

Show more